Co-Diagnostics Inc. on Friday signed an agreement for CoSara Diagnostics Pvt. Ltd, to expand its commercial and distribution ...

The global molecular diagnostics market is projected to reach USD 33.51 billion by 2031, driven by expanding precision medicine adoption and advanced genetic testing. North America leads the market, ...

CODX (NASDAQ:CODX) is making a strategic push to scale its global diagnostics platform, announcing a major expansion of ...

Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform ...

Based Platforms, Isothermal Amplification Technologies, and Lab-on-a-Chip Systems Accelerating Market Expansion Globally.Austin, United States, March 09, 2026 (GLOBE NEWSWIRE) -- Point-of-Care ...

In the following sections, we highlight ethical concerns about early adoption of molecular diagnostic testing without solid evidence or guidelines and offer practical guidance for ethical ...

The new CMS initiative dubbed CRUSH aims at cracking down on potentially fraudulent orders for molecular diagnostic tests and ...

Karan Arora, senior vice president of advanced assays, AI, and pharma services at Leica Biosystems outlines the critical role ...

To date, the limited efforts toward advancing cancer diagnostics in LMICs have focused on basic pathology services. Molecular diagnostics—now a standard part of cancer management in high-income ...

Join us for an insightful webinar on the critical role of molecular diagnostic testing for respiratory viruses during flu season. This session will explore the importance of accurate and timely ...

December 2024 was declared a "high severity" flu season by the Centre for Disease Control (CDC), the worst in over half a decade. Hospitalization rates were up to 2.8 times higher than the median ...

Expanding access to advanced PCR thermocyclers, DNA & RNA purification systems, and hematology analyzers for modern clinical laboratories ...